You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Claims for Patent: 11,266,743

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,266,743

Title:	Peptide compositions and methods of use thereof
Abstract:	Described herein are membrane permeabilizing peptides and antimicrobial peptides, polynucleotides encoding the peptides, and compositions containing the peptides. Furthermore, described herein are methods for using the peptides, polynucleotides, and compositions for research, diagnosis, and therapy.
Inventor(s):	Wimley William Charles, Starr Charles Gannon, Kauffman William Berkeley
Assignee:	The Administrators of the Tulane Educational Fund
Application Number:	US16758791
Patent Claims:

Details for Patent 11,266,743

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Microbix Biosystems Inc.	KINLYTIC	urokinase	For Injection	021846	January 16, 1978	11,266,743	2038-10-25
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	January 10, 1978	11,266,743	2038-10-25
Amgen Inc.	NEUPOGEN	filgrastim	Injection	103353	February 20, 1991	11,266,743	2038-10-25
Amgen Inc.	NEUPOGEN	filgrastim	Injection	103353	June 28, 2000	11,266,743	2038-10-25
Servier Pharmaceuticals Llc	ONCASPAR	pegaspargase	Injection	103411	February 01, 1994	11,266,743	2038-10-25
Hoffmann-la Roche Inc.	ZENAPAX	daclizumab	Injection	103749	December 10, 1997	11,266,743	2038-10-25
Novartis Pharmaceuticals Corporation	SIMULECT	basiliximab	For Injection	103764	May 12, 1998	11,266,743	2038-10-25
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,266,743

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2019084343	⤷ Get Started Free
United States of America	2020276322	⤷ Get Started Free
European Patent Office	3688011	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.